L 644711 (B-3(+))

Subscribe to Selected New Research on L 644711

200 relevant articles (6 outcomes, 16 trials/studies) found for this Bio-Agent

Description: RN given refers to (R)-isomer; structure given in first source; HCO3(-)/Cl(-) antiporter antagonist

Also Known As:

B-3(+); ((5,6-dichloro-2,3,9,9a-tetrahydro-3-oxo-9a-propyl-1H-fluoren-7-yl)oxy)acetic acid; ((5,6-dichloro-9a-n-propyl-2,3,9,9a-tetrahydro-3-oxo-1H-fluren-7-yl)oxy)acetic acid; DPOFA; L 644711, (S)-isomer; L-644,711

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Hydrocarbons: 382

Cyclic Hydrocarbons: 2

Aromatic Hydrocarbons: 115

Aromatic Polycyclic Hydrocarbons: 581

Fluorenes: 2

L 644711: 200

Polycyclic Compounds: 58

Aromatic Polycyclic Hydrocarbons: 581

Fluorenes: 2

L 644711: 200

Experts

1.	Breiteneder, H: 2 articles (08/2003 - 04/2000)
2.	Scheiner, O: 2 articles (08/2003 - 04/2000)
3.	Wagner, B: 2 articles (08/2003 - 04/2000)
4.	Van Stipdonk, Michael J: 1 article (01/2007)
5.	Chueachavalit, Chawalee: 1 article (01/2007)
6.	Talaty, Erach R: 1 article (01/2007)
7.	Osburn, Sandra: 1 article (01/2007)
8.	Utzig, N: 1 article (09/2003)
9.	Burtzlaff, C: 1 article (09/2003)
10.	Lauffer, H: 1 article (09/2003)

Related Diseases

1.	Neoplasms (Cancer) 05/01/1995 - "His postoperative pathological study was revealed intramural bronchial cancer at B 3 orifice without node involvement" 06/01/2008 - "The cancer specific mortality from group A is 24 (71%) and in group B 3 (7%) (p = 0.000)" 10/01/2007 - "All patients had T1-2 tumors with < or b=3 axillary nodes positive, nonlobular histology, negative surgical margins, and no evidence of extracapsular lymph node extension" 05/01/2007 - "Furthermore, cancer EST variations were not random, but were determined by the composition of the substituted base (b0) as well as that of the bases located upstream (up to b - 4) and downstream (up to b + 3) of the substitution event" 01/01/2004 - "The tumor was located in the macula in 33 (52%) of group A, 109 (43%) of group B, 3 (2%) of group C, and 1 (9%) of group D" Get all the results and reference details, order at left...
2.	Myocarditis (Carditis) 06/01/1991 - "An experimental study of the effect of Radix astragali on mice with viral myocarditis infected by Coxsackie B-3]" 08/01/1995 - "The data suggest (a) that a cumulative loss of cardiac myofibers, induced either by the virus and/or by immune reactions to the heart, is likely to lead to a late depression of cardiac function, and (b) that there is a weak and only temporary structure-function relationship in the heart in coxsackievirus B 3 myocarditis" 08/01/1995 - "Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis." 07/01/1981 - "A small amount of coxsackie B 3 virus frequently caused mild myocarditis without obvious residual pathologic changes of the heart, while a large amount of the same virus always caused acute and severe myocarditis" 12/01/1972 - "Murine myocarditis due to coxsackie B 3 virus: blood amino acid, virologic, and histopathologic correlates." Get all the results and reference details, order at left...
3.	Spinal Dysraphism (Spina Bifida) 04/15/2000 - "Characterization of T cell responses to Hev b 3, an allergen associated with latex allergy in spina bifida patients." 11/01/1999 - "Cloning, expression, and characterization of recombinant Hev b 3, a Hevea brasiliensis protein associated with latex allergy in patients with spina bifida." 01/01/2001 - "Development of recombinant Hev b 3, a major NRL allergen relevant to children with spina bifida, enhances the likelihood for improved diagnostic reagents" 05/01/2002 - "In addition, Hev b 3 and Hev b 1, the two major allergens for children with spina bifida, are also commonly found" 02/01/1999 - "Cloning and molecular characterization of Hev b 3, a spina-bifida-associated allergen from Hevea brasiliensis latex." Get all the results and reference details, order at left...
4.	Ischemia 03/01/1990 - "The eyes were then classified in four categories according to the extent and location of capillary nonperfusion responsible for the NVE, namely 1) generalized ischemia (Type A); 2) extensive midperipheral ischemia (Type B); 3) moderate midperipheral ischemia (Type C); and 4) peripheral ischemia (Type D)" 08/01/1986 - "Animals given dexamethasone were divided into three groups and the drug was administered at a constant dosage of 2 mg/kg: (a) 2 days, 1 day, and 3 h intraperitoneally before (chronic pretreatment), (b) 3 h intraperitoneally before (acute pretreatment), and (c) 5 min intravenously and 6 h and 1 day intraperitoneally after (chronic posttreatment) induction of ischemia" 04/01/1998 - "In the experimental protocol B, 3 min of cardioplegia without TH and 34 min of ischemia (37 degrees C) were followed by a 10 min Langendorff reperfusion with various concentrations of TH, then 10 min Langendroff reperfusion for washing out, and 20 min working reperfusion" 11/01/2003 - "Previous studies have shown that administration of vitamin B(3) (B(3)) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery" 12/08/1995 - "Ischemia was followed by either: (a) 3 h at normothermic brain temperatures, (b) 3 h of postischemic brain hypothermia at 30 degrees C, (c) hypothermia coupled with MK-801 (4 mg/kg, i.p.) on postischemic days 3, 5 and 7, or (d) postischemic MK-801 treatment alone" Get all the results and reference details, order at left...
5.	Infarction 11/01/2003 - "Previous studies have shown that administration of vitamin B(3) (B(3)) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery" Get all the results and reference details, order at left...
165 Diseases and 200 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Niacinamide (Nicotinamide)
2.	Indicators and Reagents (Reagents)
3.	Iodized Oil (Lipiodol)
4.	Win 54954
5.	Latex
6.	Allergens
7.	Immunoglobulin E (IgE)
8.	Peptides
9.	Insulin (Novolin)
10.	Acetic Acid (Vinegar)
132 Drugs and Important Bio-Agents and 85 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Hysterectomy
3.	Liver Transplantation
4.	Transplantation (Transplant Recipients)
5.	Thyroidectomy
13 Therapies and Procedures and 14 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>